Pellacani, Giovanni
Sapienza Università di Roma,
Italy
2025 Rank: 149989
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 929 out of 61090 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 149989 | 124645 |
| Total Cites | 14497 | 20230 |
| H-index | 56 | 67 |
| Hm-index | 23 | 26 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1606 | 2482 |
| Number of Single+First+Last Authored Papers | 276 | 276 |
| Total Cites to Single+First+Last Authored Papers | 5118 | 7309 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9711 | 11497 |
| Ratio of Total Citations to Distinct Citing Papers | 1.49 | 1.76 |
| Self-Citation Percentage |
28.34%
|
|
Pellacani, Giovanni
Sapienza Università di Roma,
Italy
2024 Rank: 159125
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 971 out of 57585 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 159125 | 127558 |
| Total Cites | 12311 | 17451 |
| H-index | 51 | 63 |
| Hm-index | 22 | 25 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 1491 | 2336 |
| Number of Single+First+Last Authored Papers | 250 | 250 |
| Total Cites to Single+First+Last Authored Papers | 4522 | 6561 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8181 | 9753 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.79 |
| Self-Citation Percentage |
29.45%
|
|
Pellacani, Giovanni
Sapienza Università di Roma,
Italy
2023 Rank: 160912
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 989 out of 54095 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 160912 | 126803 |
| Total Cites | 10608 | 15343 |
| H-index | 47 | 61 |
| Hm-index | 21 | 24 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 1402 | 2234 |
| Number of Single+First+Last Authored Papers | 233 | 233 |
| Total Cites to Single+First+Last Authored Papers | 4050 | 5989 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6973 | 8371 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.83 |
| Self-Citation Percentage |
30.86%
|
|
Pellacani, Giovanni
Università degli Studi di Modena e Reggio Emilia,
Italy
2021 Rank: 164205
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Dermatology & Venereal Diseases
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1025 out of 49699 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 164205 | 129613 |
| Total Cites | 8239 | 12221 |
| H-index | 42 | 53 |
| Hm-index | 19 | 22 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 40 | 40 |
| Total Cites to Single+First Authored Papers | 1258 | 2043 |
| Number of Single+First+Last Authored Papers | 196 | 196 |
| Total Cites to Single+First+Last Authored Papers | 3331 | 5049 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5293 | 6412 |
| Ratio of Total Citations to Distinct Citing Papers | 1.56 | 1.91 |
| Self-Citation Percentage |
32.58%
|
|